The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hybridization of denatured RNA and small DNA fragments transferred to nitrocellulose.
Thomas, P. S. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.9.5201 · Cited by 8,156
Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes
Land, H., Parada, L. F., & Weinberg, R. A. (1983) · Nature · doi:10.1038/304596a0 · Cited by 2,804
Cell-specific regulation of the c-myc gene by lymphocyte mitogens and platelet-derived growth factor
Kelly, K., Cochran, B. H., Stiles, C. D., & Leder, P. (1983) · Cell · doi:10.1016/0092-8674(83)90092-2 · Cited by 2,296
CELLULAR ONCOGENES AND RETROVIRUSES
Bishop, J. M. (1983) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.52.070183.001505 · Cited by 1,641
Activation of a cellular onc gene by promoter insertion in ALV-induced lymphoid leukosis
Hayward, W. S., Neel, B. G., & Astrin, S. M. (1981) · Nature · doi:10.1038/290475a0 · Cited by 1,567
Banerji, J., Olson, L., & Schaffner, W. (1983) · Cell · doi:10.1016/0092-8674(83)90015-6 · Cited by 1,407
Gillies, S. D., Morrison, S. L., Oi, V. T., & Tonegawa, S. (1983) · Cell · doi:10.1016/0092-8674(83)90014-4 · Cited by 1,361
Hanahan, D. (1985) · Nature · doi:10.1038/315115a0 · Cited by 1,281
Factors affecting the efficiency of introducing foreign DNA into mice by microinjecting eggs.
Brinster, R. L., Chen, H. Y., Trumbauer, M. E., Yagle, M. K., & Palmiter, R. D. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.13.4438 · Cited by 1,027
Self-citationSpontaneous mammary adenocarcinomas in transgenic mice that carry and express MTV/myc fusion genes
Stewart, T. A., Pattengale, P. K., & Leder, P. (1984) · Cell · doi:10.1016/0092-8674(84)90257-5 · Cited by 899
Cited by
Items 101–174 of 174
Hemann, M. T., Fridman, J. S., Zilfou, J. T., Hernando, E., Paddison, P. J., Cordon-Cardo, C., Hannon, G. J., & Lowe, S. W. (2003) · Nature Genetics · doi:10.1038/ng1091 · Cited by 354
JNK signalling in cancer: in need of new, smarter therapeutic targets
Bubici, C., & Papa, S. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12432 · Cited by 346
Activation Of Cellular Oncogenes in Hemopoietic Cells by Chromosome Translocation
(1986) · Advances in Cancer Research · doi:10.1016/s0065-230x(08)60200-6 · Cited by 343
Tip60 is a haplo-insufficient tumour suppressor required for an oncogene-induced DNA damage response
Gorrini, C., Squatrito, M., Luise, C., Syed, N., Perna, D., Wark, L., Martinato, F., Sardella, D., Verrecchia, A., Bennett, S., et al. (2007) · Nature · doi:10.1038/nature06055 · Cited by 343
Expression of Epstein-Barr virus nuclear antigen-1 induces B cell neoplasia in transgenic mice.
Wilson, J. B., Bell, J. L., & Levine, A. J. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00674.x · Cited by 334
Deregulated c-fos expression interferes with normal bone development in transgenic mice
Rüther, U., Garber, C., Komitowski, D., Müller, R., & Wagner, E. F. (1987) · Nature · doi:10.1038/325412a0 · Cited by 332
Essential role of stromally induced hedgehog signaling in B-cell malignancies
Dierks, C., Grbic, J., Zirlik, K., Beigi, R., Englund, N. P., Guo, G.-R., Veelken, H., Engelhardt, M., Mertelsmann, R., Kelleher, J. F., et al. (2007) · Nature Medicine · doi:10.1038/nm1614 · Cited by 329
Tumor-Suppressor Functions of the TP53 Pathway
Aubrey, B. J., Strasser, A., & Kelly, G. L. (2016) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a026062 · Cited by 327
Inhibition of CDK1 as a potential therapy for tumors over-expressing MYC
Goga, A., Yang, D., Tward, A. D., Morgan, D. O., & Bishop, J. M. (2007) · Nature Medicine · doi:10.1038/nm1606 · Cited by 326
New light on Myc and Myb. Part I. Myc.
Luscher, B., & Eisenman, R. N. (1990) · Genes & Development · doi:10.1101/gad.4.12a.2025 · Cited by 326
Brewer, G., & Ross, J. (1988) · Molecular and Cellular Biology · doi:10.1128/mcb.8.4.1697 · Cited by 315
Short Telomeres Limit Tumor Progression In Vivo by Inducing Senescence
Feldser, D. M., & Greider, C. W. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.02.026 · Cited by 314
PML Is a Direct p53 Target that Modulates p53 Effector Functions
de Stanchina, E., Querido, E., Narita, M., Davuluri, R. V., Pandolfi, P. P., Ferbeyre, G., & Lowe, S. W. (2004) · Molecular Cell · doi:10.1016/s1097-2765(04)00062-0 · Cited by 312
Analysis of genomic targets reveals complex functions of MYC
Patel, J. H., Loboda, A. P., Showe, M. K., Showe, L. C., & McMahon, S. B. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1393 · Cited by 312
Inhibitors of histone acetyltransferases KAT6A/B induce senescence and arrest tumour growth
Baell, J. B., Leaver, D. J., Hermans, S. J., Kelly, G. L., Brennan, M. S., Downer, N. L., Nguyen, N., Wichmann, J., McRae, H. M., Yang, Y., et al. (2018) · Nature · doi:10.1038/s41586-018-0387-5 · Cited by 310
Intragenic pausing and anti-sense transcription within the murine c-myc locus.
Nepveu, A., & Marcu, K. B. (1986) · The EMBO Journal · doi:10.1002/j.1460-2075.1986.tb04580.x · Cited by 309
Twa, D. D. W., Chan, F. C., Ben-Neriah, S., Woolcock, B. W., Mottok, A., Tan, K. L., Slack, G. W., Gunawardana, J., Lim, R. S., McPherson, A. W., et al. (2014) · Blood · doi:10.1182/blood-2013-10-535443 · Cited by 302
Epstein–Barr virus and Burkitt lymphoma
Brady, G., MacArthur, G. J., & Farrell, P. J. (2008) · Postgraduate Medical Journal · doi:10.1136/jcp.2007.047977 · Cited by 301
Lombardi, L., Newcomb, E. W., & Dalla-Favera, R. (1987) · Cell · doi:10.1016/0092-8674(87)90556-3 · Cited by 295
mTORC1 promotes survival through translational control of Mcl-1
Mills, J. R., Hippo, Y., Robert, F., Chen, S. M. H., Malina, A., Lin, C.-J., Trojahn, U., Wendel, H.-G., Charest, A., Bronson, R. T., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0804821105 · Cited by 285
Baron, B. W., Nucifora, G., McCabe, N., Espinosa, R., Le Beau, M. M., & McKeithan, T. W. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.11.5262 · Cited by 287
Pourdehnad, M., Truitt, M. L., Siddiqi, I. N., Ducker, G. S., Shokat, K. M., & Ruggero, D. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1310230110 · Cited by 286
Tam, W., Ben-Yehuda, D., & Hayward, W. S. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.3.1490 · Cited by 285
The curious case of the tumour virus: 50 years of Burkitt's lymphoma
Thorley-Lawson, D. A., & Allday, M. J. (2008) · Nature Reviews Microbiology · doi:10.1038/nrmicro2015 · Cited by 282
Expression of Bcl-2 and Bcl-2-Ig fusion transcripts in normal and neoplastic cells.
Graninger, W. B., Seto, M., Boutain, B., Goldman, P., & Korsmeyer, S. J. (1987) · Journal of Clinical Investigation · doi:10.1172/jci113235 · Cited by 281
Transgenic Models of Tumor Development
Adams, J. M., & Cory, S. (1991) · Science · doi:10.1126/science.1957168 · Cited by 280
Self-citationDeletions linked to TP53 loss drive cancer through p53-independent mechanisms
Liu, Y., Chen, C., Xu, Z., Scuoppo, C., Rillahan, C. D., Gao, J., Spitzer, B., Bosbach, B., Kastenhuber, E. R., Baslan, T., et al. (2016) · Nature · doi:10.1038/nature17157 · Cited by 279
Genetic analysis of chemoresistance in primary murine lymphomas
Schmitt, C. A., Rosenthal, C. T., & Lowe, S. W. (2000) · Nature Medicine · doi:10.1038/79542 · Cited by 278
Bailleul, B., Surani, M. A., White, S., Barton, S. C., Brown, K., Blessing, M., Jorcano, J., & Balmain, A. (1990) · Cell · doi:10.1016/0092-8674(90)90115-u · Cited by 277
Chromosome translocations: dangerous liaisons revisited
Rowley, J. D. (2001) · Nature Reviews Cancer · doi:10.1038/35106108 · Cited by 274
Maclean, K. H., Dorsey, F. C., Cleveland, J. L., & Kastan, M. B. (2008) · Journal of Clinical Investigation · doi:10.1172/jci33700 · Cited by 272
Retroviral insertional mutagenesis: past, present and future
Uren, A. G., Kool, J., Berns, A., & van Lohuizen, M. (2005) · Oncogene · doi:10.1038/sj.onc.1209043 · Cited by 271
Freytag, S. O. (1988) · Molecular and Cellular Biology · doi:10.1128/mcb.8.4.1614 · Cited by 271
Kollias, G., Wrighton, N., Hurst, J., & Grosveld, F. (1986) · Cell · doi:10.1016/0092-8674(86)90862-7 · Cited by 268
Chemical Carcinogenesis: From Animal Models To Molecular Models In One Decade
(1988) · Advances in Cancer Research · doi:10.1016/s0065-230x(08)60434-0 · Cited by 267
Herrscher, R. F., Kaplan, M. H., Lelsz, D. L., Das, C., Scheuermann, R., & Tucker, P. W. (1995) · Genes & Development · doi:10.1101/gad.9.24.3067 · Cited by 267
Alterations in the apoptotic machinery and their potential role in anticancer drug resistance
Kaufmann, S. H., & Vaux, D. L. (2003) · Oncogene · doi:10.1038/sj.onc.1206945 · Cited by 265
ATF4 couples MYC-dependent translational activity to bioenergetic demands during tumour progression
Tameire, F., Verginadis, I. I., Leli, N. M., Polte, C., Conn, C. S., Ojha, R., Salas Salinas, C., Chinga, F., Monroy, A. M., Fu, W., et al. (2019) · Nature Cell Biology · doi:10.1038/s41556-019-0347-9 · Cited by 264
Myc Recruits P-TEFb to Mediate the Final Step in the Transcriptional Activation of the cad Promoter
Eberhardy, S. R., & Farnham, P. J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m207441200 · Cited by 262
McGuire, E. A., Hockett, R. D., Pollock, K. M., Bartholdi, M. F., O'Brien, S. J., & Korsmeyer, S. J. (1989) · Molecular and Cellular Biology · doi:10.1128/mcb.9.5.2124 · Cited by 262
Pancreatic neoplasia induced by ras expression in acinar cells of transgenic mice
Quaife, C. J., Pinkert, C. A., Ornitz, D. M., Palmiter, R. D., & Brinster, R. L. (1987) · Cell · doi:10.1016/0092-8674(87)90710-0 · Cited by 262
Self-citationCunningham, J. T., Moreno, M. V., Lodi, A., Ronen, S. M., & Ruggero, D. (2014) · Cell · doi:10.1016/j.cell.2014.03.052 · Cited by 260
LINDSAYWILLIAMS, R. (1988) · Cell · doi:10.1016/0092-8674(88)90536-3 · Cited by 259
Myc Roles in Hematopoiesis and Leukemia
Delgado, M. D., & Leon, J. (2010) · Genes & Cancer · doi:10.1177/1947601910377495 · Cited by 255
MYC Oncogene Contributions to Release of Cell Cycle Brakes
García-Gutiérrez, L., Delgado, M. D., & León, J. (2019) · Genes · doi:10.3390/genes10030244 · Cited by 255
p53 is frequently mutated in Burkitt's lymphoma cell lines
Farrell, P. J., Allan, G. J., Shanahan, F., Vousden, K. H., & Crook, T. (1991) · The EMBO Journal · doi:10.1002/j.1460-2075.1991.tb07837.x · Cited by 254
Regulation of lymphoid-specific immunoglobulin mu heavy chain gene enhancer by ETS-domain proteins
Nelsen, B., Tian, G., Erman, B., Gregoire, J., Maki, R., Graves, B., & Sen, R. (1993) · Science · doi:10.1126/science.8316859 · Cited by 222
Intact p53-Dependent Responses in miR-34–Deficient Mice
Concepcion, C. P., Han, Y.-C., Mu, P., Bonetti, C., Yao, E., D'Andrea, A., Vidigal, J. A., Maughan, W. P., Ogrodowski, P., & Ventura, A. (2012) · PLoS Genetics · doi:10.1371/journal.pgen.1002797 · Cited by 197
Tumor Stroma-Derived TGF-β Limits Myc-Driven Lymphomagenesis via Suv39h1-Dependent Senescence
Reimann, M., Lee, S., Loddenkemper, C., Dörr, J. R., Tabor, V., Aichele, P., Stein, H., Dörken, B., Jenuwein, T., & Schmitt, C. A. (2010) · Cancer Cell · doi:10.1016/j.ccr.2009.12.043 · Cited by 184
Bent, E. H., Gilbert, L. A., & Hemann, M. T. (2016) · Genes & Development · doi:10.1101/gad.284851.116 · Cited by 179
Tissue-specific and reversible RNA interference in transgenic mice
Dickins, R. A., McJunkin, K., Hernando, E., Premsrirut, P. K., Krizhanovsky, V., Burgess, D. J., Kim, S. Y., Cordon-Cardo, C., Zender, L., Hannon, G. J., et al. (2007) · Nature Genetics · doi:10.1038/ng2045 · Cited by 174
Lymphoma‐ and leukemia‐associated chromosomal translocations in healthy individuals
Janz, S., Potter, M., & Rabkin, C. S. (2003) · Genes, Chromosomes and Cancer · doi:10.1002/gcc.10178 · Cited by 149
Efficacy of CHK inhibitors as single agents in MYC-driven lymphoma cells
Ferrao, P. T., Bukczynska, E. P., Johnstone, R. W., & McArthur, G. A. (2012) · Oncogene · doi:10.1038/onc.2011.358 · Cited by 133
Mutations in the RNA Splicing Factor SF3B1 Promote Tumorigenesis through MYC Stabilization
Liu, Z., Yoshimi, A., Wang, J., Cho, H., Chun-Wei Lee, S., Ki, M., Bitner, L., Chu, T., Shah, H., Liu, B., et al. (2020) · Cancer Discovery · doi:10.1158/2159-8290.cd-19-1330 · Cited by 118
Mdm2 haplo‐insufficiency profoundly inhibits Myc‐induced lymphomagenesis
Alt, J. R., Greiner, T. C., Cleveland, J. L., & Eischen, C. M. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg133 · Cited by 129
Finkle, D., Quan, Z. R., Asghari, V., Kloss, J., Ghaboosi, N., Mai, E., Wong, W. L., Hollingshead, P., Schwall, R., Koeppen, H., et al. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0448 · Cited by 125
SIRT4 protein suppresses tumor formation in genetic models of Myc-induced B cell lymphoma
Jeong, S. M., Lee, A., Lee, J., & Haigis, M. C. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.525949 · Cited by 121
Schatz, J. H., Oricchio, E., Wolfe, A. L., Jiang, M., Linkov, I., Maragulia, J., Shi, W., Zhang, Z., Rajasekhar, V. K., Pagano, N. C., et al. (2011) · Journal of Experimental Medicine · doi:10.1084/jem.20110846 · Cited by 119
Haploinsufficiency of Mdm2 and Mdm4 in Tumorigenesis and Development
Terzian, T., Wang, Y., Van Pelt, C. S., Box, N. F., Travis, E. L., & Lozano, G. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.00555-06 · Cited by 116
BCL-2 family member BOK is widely expressed but its loss has only minimal impact in mice
Ke, F., Voss, A., Kerr, J. B., O'Reilly, L. A., Tai, L., Echeverry, N., Bouillet, P., Strasser, A., & Kaufmann, T. (2012) · Cell Death & Differentiation · doi:10.1038/cdd.2011.210 · Cited by 113
Short-term gain, long-term pain: the senescence life cycle and cancer
Chan, A. S. L., & Narita, M. (2019) · Genes & Development · doi:10.1101/gad.320937.118 · Cited by 80
Wang, P., Lushnikova, T., Odvody, J., Greiner, T. C., Jones, S. N., & Eischen, C. M. (2008) · Oncogene · doi:10.1038/sj.onc.1210788 · Cited by 86
Validation of MdmX as a therapeutic target for reactivating p53 in tumors
Garcia, D., Warr, M. R., Martins, C. P., Brown Swigart, L., Passegué, E., & Evan, G. I. (2011) · Genes & Development · doi:10.1101/gad.16722111 · Cited by 83
Wang, Y. V., Leblanc, M., Wade, M., Jochemsen, A. G., & Wahl, G. M. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.05.008 · Cited by 79
Wall, M., Poortinga, G., Stanley, K. L., Lindemann, R. K., Bots, M., Chan, C. J., Bywater, M. J., Kinross, K. M., Astle, M. V., Waldeck, K., et al. (2013) · Cancer Discovery · doi:10.1158/2159-8290.cd-12-0404 · Cited by 64
Shah, M. Y., Vasanthakumar, A., Barnes, N. Y., Figueroa, M. E., Kamp, A., Hendrick, C., Ostler, K. R., Davis, E. M., Lin, S., Anastasi, J., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-0847 · Cited by 63
Max deletion destabilizes MYC protein and abrogates Eµ- Myc lymphomagenesis
Mathsyaraja, H., Freie, B., Cheng, P.-F., Babaeva, E., Catchpole, J. T., Janssens, D., Henikoff, S., & Eisenman, R. N. (2019) · Genes & Development · doi:10.1101/gad.325878.119 · Cited by 54
Widespread Overexpression of Epitope-Tagged Mdm4 Does Not Accelerate Tumor Formation In Vivo
De Clercq, S., Gembarska, A., Denecker, G., Maetens, M., Naessens, M., Haigh, K., Haigh, J. J., & Marine, J.-C. (2010) · Molecular and Cellular Biology · doi:10.1128/mcb.00330-10 · Cited by 35
“B-cell lineage and consequently develop spontaneous B-cell lymphoma (1).”
BackgroundMethodEssential Role of Phospholipase Cγ2 in Early B-Cell Development and Myc-Mediated Lymphomagenesis
Wen, R., Chen, Y., Bai, L., Fu, G., Schuman, J., Dai, X., Zeng, H., Yang, C., Stephan, R. P., Cleveland, J. L., et al. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.00839-06 · Cited by 34
Insertion of Myc into Igh Accelerates Peritoneal Plasmacytomas in Mice
Park, S. S., Shaffer, A. L., Kim, J. S., duBois, W., Potter, M., Staudt, L. M., & Janz, S. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1222 · Cited by 27
Anti-c-myc RNAi-Based Onconanotherapeutics
Habib, S., Ariatti, M., & Singh, M. (2020) · Biomedicines · doi:10.3390/biomedicines8120612 · Cited by 23
Sénéchal, P., Robert, F., Cencic, R., Yanagiya, A., Chu, J., Sonenberg, N., Paquet, M., & Pelletier, J. (2021) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-021-03940-5 · Cited by 20
Liu, S., Wu, B., Li, X., Zhao, L., Wu, W., & Ai, S. (2021) · Journal of Oncology · doi:10.1155/2021/2719172 · Cited by 15
Insertional mutagenesis inducing hypomyelination in transgenic mice
Orian, J. M., Mitchell, A. W. S., Marshman, W. E., Webb, G. C., Ayers, M. M., Grail, D., Ford, J. H., Kaye, A. H., & Gonzales, M. F. (1994) · Journal of Neuroscience Research · doi:10.1002/jnr.490390512 · Cited by 8
Metadata
- Authors
- Adams, J. M., Harris, A. W., Pinkert, C. A., Corcoran, L. M., Alexander, W. S., Cory, S., Palmiter, R. D., & Brinster, R. L.
- Venue
- Nature
- Published
- 1985-12
- Volume
- 318
- Issue
- 6046
- Pages
- 533-538
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1968075576
- Cited by
- 1,779
- References
- 49
- FWCI
- 67.67
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.